HOME › Research Insight › New Product Launches Was the Key Growth Strategy in the Glycomics Enzymes, Instruments, Kits and Reagents Market between 2011 and 2014
New Product Launches Was the Key Growth Strategy in the Glycomics Enzymes, Instruments, Kits and Reagents Market between 2011 and 2014
Glycomics is increasingly being used in all fields of life science research, including drug discovery, diagnostics, immunology, and oncology. Glycomics is the study of glycan structures on biomolecules. The growth of the glycomics market will be driven by increased funding for proteomics and glycomics research, and increased research activities related to drug discovery.
The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S.).
The global glycomics market is highly evolved, with multiple different product segments. An analysis of market developments between 2011 and 2014 revealed that new product launches was the most important growth strategy employed by market leaders in this period. This strategy was adopted by most players in this market, except New England Biolabs (U.S.) and Takara Bio, Inc. (Japan).
The other important growth strategy adopted by players in this market was expansion. This strategy was implemented to gain immediate technological competency and widen geographic presence. This strategy was adopted by all the players in this market, except Prozyme, Inc. (U.S.), and Waters Corporation (U.S.). Unlike their peers, these companies did not enter into any expansions between 2011 and 2014.
Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments (HPLC, Mass Spectrometry, MALDI-TOF), Kits, and Reagents], Application (Immunology, Oncology) & by End User - Global Forecast to 2019
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252